Verastem, Inc. (VSTM) Key Metrics

NASDAQ: VSTMValuation, returns, debt and efficiency ratios over 10 years.

VSTM valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$783.4M
Enterprise value
$688.3M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
9.0
Price / book
14.8
EV / EBITDA
—
Dividend yield
—
Beta
0.39

VSTM key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

VSTM valuation Price multiples at each fiscal year-end price.

Price / sales−6.3%
17.3
2025 · hover or tap a bar for each year
2024: 18.52025: 17.3 (−6.3%)
20162025
Price / book
9.4
2025 · hover or tap a bar for each year
2023: 3.12025: 9.4
20162025
Free cash flow yield+31.1 pts
−25.7%
2025 · hover or tap a bar for each year
2023: −48.2%2024: −56.8% (−8.6 pts)2025: −25.7% (+31.1 pts)
20162025

VSTM valuation history

Fiscal year-endToday10-year median

VSTM returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

VSTM debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

VSTM cash returned to shareholders

DividendsBuybacksFree cash flow

VSTM price vs earnings per share

Share price at year-endEPS (right axis)

VSTM key metrics

2016–2025
Verastem, Inc. key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$535.1M$184.6M$179.5M———————
Enterprise value$406.9M$138.1M$83.9M———————
Price / sales17.318.5————————
Price / book9.4—3.1———————
EV / sales13.213.8————————
Earnings yield−39.1%−70.8%−48.7%———————
Free cash flow yield−25.7%−56.8%−48.2%———————
Share price at fiscal year-end$7.72$5.17$8.14$4.83$24.60$25.56$16.08$40.32$36.84$13.44
Per share
Revenue per share$0.45$0.28$0.00———————
Earnings per share−$3.02−$3.66−$3.96———————
Operating cash flow per share−$1.98−$2.93−$3.92———————
Free cash flow per share−$1.98−$2.93−$3.92———————
Cash per share$2.96$2.49$6.22———————
Book value per share$0.83−$0.81$2.60———————
Tangible book value per share$0.59−$0.81$2.60———————
Capex per share$0.14$0.00$0.00———————
Debt per share$1.11$1.18$1.88———————
Shares outstanding69.3M35.7M22.1M———————
Change in shares outstanding+94.1%+61.9%————————
Returns & profitability
Return on equity (ROE)——−166.8%−109.4%−70.2%−110.6%−227.0%−79.6%−104.3%−41.7%
Return on invested capital (ROIC)——————−609.6%———
Return on assets (ROA)−120.4%−104.0%−71.4%−72.5%−54.1%−45.2%−70.7%−39.5%−78.2%−37.0%
Return on tangible assets−91.1%−128.7%−58.4%−77.7%−65.5%−43.9%−119.3%−28.3%−75.5%−43.6%
Free cash flow margin−444.8%————−37.9%−793.6%−366.9%——
Financial health
Total debt$76.9M$42.3M$41.6M$27.1M$3.2M$22.5M$107.5M$120.5M$14.8M$0
Cash & short-term investments$205.0M$88.8M$137.1M$87.9M$100.3M$141.2M$75.5M$249.7M$86.7M$80.9M
Net debt−$128.1M−$46.6M−$95.6M−$60.8M−$97.1M−$118.7M$32.0M−$129.2M−$71.8M−$80.9M
Debt / equity1.34—0.720.570.040.2014.990.970.260.00
Debt / assets0.310.420.280.280.030.150.740.430.170.00
Current ratio3.093.075.454.295.698.482.846.835.137.40
Quick ratio3.073.075.454.2911.118.482.746.825.137.40
Interest coverage-149.5-25.2-22.2-34.1-6.2-3.1-6.4-16.3-121.3—
Working capital$151.1M$64.0M$117.3M$71.2M$87.2M$127.8M$55.1M$216.2M$70.7M$70.3M
Invested capital−$70.9M−$75.5M−$38.2M−$13.4M−$9.5M−$3.4M$39.2M−$4.9M−$14.2M−$8.6M
Tangible asset value$40.8M−$28.9M$57.4M$47.4M$87.6M$115.3M−$12.8M$102.7M$57.7M$72.3M
Net current asset value$34.2M−$35.5M$51.3M$45.2M$84.6M$105.9M−$52.9M$100.3M$55.7M$70.0M
Graham net-net per share$0.34−$1.16$2.03———————
Capital allocation
Dividends paid———$0$0$0$15,000—$0$0
Share buybacks (net)———$0$925,000$285,000$68,000$0$0$0
Capex / revenue31.1%0.3%—0.0%9.5%0.0%0.0%88.0%——
Capex / depreciation13.221.080.110.002.720.030.0016.572.710.06
Stock-based compensation / revenue30.4%73.4%—232.9%375.6%9.2%48.9%25.0%——
R&D / revenue370.7%813.3%—1,947.5%1,916.6%46.7%262.2%163.4%——
SG&A / revenue262.5%436.2%—962.1%1,174.6%70.9%579.8%289.2%——
Efficiency
Days sales outstanding53.24.4—38.567.15.729.64.2——
Days of inventory on hand63.1———-89,276.2—222.5101.5——
Days payables outstanding567.578,685.635,572.811,140.23,700.562.41,294.36,033.44,359.32,189.2
Cash conversion cycle (days)-451.1-78,681.2—-11,101.8-92,909.5-39.9-1,042.2-5,927.7——
Receivables turnover6.8682.640.009.495.4464.0712.3487.31—0.00
Payables turnover0.640.000.010.030.105.850.280.060.080.17
Inventory turnover5.78—————1.643.60——
Asset turnover0.180.080.000.030.020.590.080.150.000.00
Average receivables$4.5M$121,000$36,500$273,500$377,500$1.4M$1.4M$306,000—$179,000
Average payables$8.2M$5.6M$6.0M$3.6M$2.1M$5.8M$10.0M$9.7M$6.6M$4.0M
Average inventory$916,500$0——−$50.4M$1.5M$1.7M$163,500$0−$77,000
Intangibles / total assets6.7%0.0%0.0%0.0%0.0%0.0%13.8%7.8%0.0%0.0%

Computed from VSTM's annual financial statements (latest annual report filed March 4, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

VSTM valuation and financial ratios

It ended the year with $76.9 million of debt and $205.0 million in cash and short-term investments, a net cash position of $128.1 million.

See the VSTM income statement, the VSTM chart for price history, or the VSTM stock overview for the latest quote and news.

VSTM key metrics FAQ

How much debt does Verastem have?

Verastem had total debt of $76.9 million at the end of fiscal 2025, a debt-to-equity ratio of 1.34 and more cash than debt.

What is Verastem's free cash flow yield?

Verastem generated -$137.5 million of free cash flow in fiscal 2025, a free cash flow yield of −25.7% on its market value at year-end ($535.1 million).

What is Verastem's current ratio?

Verastem's current ratio was 3.09 at the end of fiscal 2025: current assets were 3.09 times current liabilities.

Biotechnology key metrics